RTN4RL2
Reticulon-4 receptor-like 2
Also known as: NgR2, NGRH1, R4RL2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86UN3
- Gene
- RTN4RL2
- Ensembl
- ENSG00000186907
- Chromosome
- 11
- Canonical length
- 420 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
Enables signaling receptor activity. Predicted to be involved in cell surface receptor signaling pathway; corpus callosum development; and negative regulation of neuron projection development. Located in cell surface and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
420 residues, UniProt reviewed canonical sequence.
>Q86UN3|RTN4RL2
1 MLPGLRRLLQ APASACLLLM LLALPLAAPS CPMLCTCYSS PPTVSCQANN FSSVPLSLPP
61 STQRLFLQNN LIRTLRPGTF GSNLLTLWLF SNNLSTIYPG TFRHLQALEE LDLGDNRHLR
121 SLEPDTFQGL ERLQSLHLYR CQLSSLPGNI FRGLVSLQYL YLQENSLLHL QDDLFADLAN
181 LSHLFLHGNR LRLLTEHVFR GLGSLDRLLL HGNRLQGVHR AAFRGLSRLT ILYLFNNSLA
241 SLPGEALADL PSLEFLRLNA NPWACDCRAR PLWAWFQRAR VSSSDVTCAT PPERQGRDLR
301 ALREADFQAC PPAAPTRPGS RARGNSSSNH LYGVAEAGAP PADPSTLYRD LPAEDSRGRQ
361 GGDAPTEDDY WGGYGGEDQR GEQMCPGAAC QAPPDSRGPA LSAGLPSPLL CLLLLVPHHLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RTN4RL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- liver: 38 nTPM
- cerebral cortex: 34 nTPM
- thyroid gland: 29 nTPM
- amygdala: 17 nTPM
- hippocampal formation: 16 nTPM
- skin: 4.1 nTPM
Single-cell type
- retinal bipolar cells: 25 nCPM
- hepatocytes: 19 nCPM
- late primary spermatocytes: 19 nCPM
- brain excitatory neurons: 15 nCPM
- oligodendrocyte progenitor cells: 12 nCPM
- extravillous trophoblasts: 12 nCPM
Immune cell
- myeloid DC: 1 nTPM
- intermediate monocyte: 0.6 nTPM
- classical monocyte: 0.3 nTPM
- MAIT T-cell: 0.3 nTPM
- naive CD8 T-cell: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- cerebral cortex: 116 nTPM
- hippocampal formation: 86 nTPM
- amygdala: 72 nTPM
- basal ganglia: 61 nTPM
- white matter: 50 nTPM
- medulla oblongata: 7.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.88
- gnomAD missense Z
- 2.47
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon regeneration
- cell surface receptor signaling pathway
- corpus callosum development
- negative regulation of neuron projection development
- positive regulation of synapse assembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RTN4RL2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RTN4RL2 as an antibody target. Whether an autoantibody or antibody against RTN4RL2 could matter depends on whether native RTN4RL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RTN4RL2 is annotated at the cell surface, where native RTN4RL2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RTN4RL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...